3557 results for «223»
3557 results
Essentials of lifetime management of TAVR patients using novel Myval THV
05 Dec 2023 – From GulfPCR-GIM 2023
Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...

Evidence gap and new indications
05 Dec 2023 – From GulfPCR-GIM 2023
Follow discussions about a 74-year-old patient with NYHA III.IV dyspnea, DM, HTN, paroxismal AF and LVEF 20% to find out more about symptomatic moderate aortic stenosis, and about an 84-year-old patient with dyspnea NYHA III, HTN, no significant CAD, and follow-up for moderate aortic regurgitation, and...

Valve-in-valve: not as simple as it looks
05 Dec 2023 – From GulfPCR-GIM 2023
Thanks to this session, you will enhance your comprehension of anticipating, planning, and executing TAV-in-TAV procedures, and gain insights into preventing coronary obstruction during these interventions.

From access to annulus: overcoming challenging anatomies
05 Dec 2023 – From GulfPCR-GIM 2023
Gain expertise in selecting the appropriate TAVI device for achieving stable deployment in a 90-degree horizontal aorta. Discover techniques for ensuring smooth deliverability, particularly when navigating through tight and tortuous anatomies. Additionally, learn strategies to prepare for future coronary access, irrespective of the height of the...

GulfPCR-GIM 2023 Opening Ceremony
06 Dec 2023 – From GulfPCR-GIM 2023
After a short presentation of the Course Directors and co-Directors, as well as the programme committee Members, find out more about the program, content and new features of this two-day Course, and learn more about the "GulfWIN" initiative, launched last year, which puts women at the heart...

Challenging scenarios in cardiogenic shock
06 Dec 2023 – From GulfPCR-GIM 2023
Thanks to this session, explore the physiology and stages of cardiogenic shock and diverse modalities for its treatment, and acquire proficiency in managing patients undergoing high-risk PCI with cardiogenic shock.

Learning bifurcation PCI
06 Dec 2023 – From GulfPCR-GIM 2023
Through the case of a 72-year-old hypertensive patient presenting with chest pain that had been there for 15 days but had suddenly intensified, followed by that of a second patient suffering from side-branch stenosis, learn more about provisional stenting and the two-stent strategy, and explore the...

Latest developments in interventional valve therapies
06 Dec 2023 – From GulfPCR-GIM 2023
In this GulfPCR-GIM 2023 session, learn more about RESILIA, the calcium-blocking tissue found in Edwards' newest innovative system: the Sapien 3 Ultra Resilia. Then, move on from TAVI to the first mitral transcatheter edge-to-edge repair (TEER) performed in the Middle East using the PASCAL Precision System.

Challenging structural interventions: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
In these slides, explore a selection of cases focusing on challenging structural interventions, with a case of complex bicuspid aortic valve, and a special focus on TAVI dysfunction.

Renal denervation 2.0 - Ready for clinical use?
06 Dec 2023 – From GulfPCR-GIM 2023
Stay updated on the latest clinical evidence, guidelines, and technology related to renal denervation. Engage in discussions about the clinical experiences with ultrasound renal denervation (uRDN) and gain practical insights into selecting patients through real-world cases.

Tailored approaches to complex bifurcation PCI: part 2
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session to discover various complex PCI bifurcation cases, and learn more about the step by step approach on how to treat an ostial LAD lesion, and relevant procedures, such as the cutting balloon angioplasty, CABG or the trifurctional intervention.

Complex left main PCI: ancillary tools for safer interventions
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session to discover complex left main PCI cases, such as a severe stenosis in the distal left main bifurcation and differentiating atherosclerotic lesions from catheter-induced vasospasm, explore effective techniques such as imaging-guided optimisation for complex angioplasty, and more!

When complications storm through the cathlab: part 3
07 Dec 2023 – From GulfPCR-GIM 2023
These slides focus on complications that may occur during PCI in the cathlab. Through the lens of this case, be prepared about what type of complications one might face during PCI, and get updates on the latest guidelines and tools developed for emergencies.

First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent vs a durable fluoropolymer-based everolimus-eluting stent in patients with CAD: the ANGIOLITE trial
14 Jan 2020
The durable fluoroacrylate polymer-based sirolimus-eluting stent (Angiolite SES) has shown promising preclinical and clinical results regarding inflammatory vascular reaction and neointimal healing. J. Moreu, et al. aimed to compare performance between the Angiolite SES and an everolimus-eluting stent (EES) in patients with coronary artery disease.
Authors :

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Author

Does metallic stent ablation by rotational atherectomy influence on the coronary microcirculation?
09 Jul 2019
An 80-year-old man underwent percutaneous coronary intervention with a bare-metal stent for severe stenosis at proximal left anterior descending coronary artery 13 years ago. In-stent restenosis was treated by a drug-eluting stent 1 year later...

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Author
